Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients

Transplant Infectious Disease(2023)10.1111/tid.14182Source: DataRank Database

Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients is a research paper published in Transplant Infectious Disease (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.36)OA: hybridTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Sandy Joung ORCID,Minhao Wang ORCID,Teresa Tran,Michelle Bravo ORCID,Hibah Masoom

Live enrichment

PubMed:37885435 PMC:PMC10922395 OpenAlex:https://openalex.org/W4387966483

NHLBI NIH HHS

Grant: R01 HL151828

NIH HHS

Grant: K23HL153888

NHLBI NIH HHS

Grant: R01 HL131532

FWCI

1.36

Citation Percentile

0.8%

Citation Trend

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tid.14182

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tid.14182

journalhttps://doi.org/10.1111/tid.14182

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37885435

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10922395

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRenal Transplantation Outcomes and TreatmentsHumansCOVID-19SARS-CoV-2Antibodies, MonoclonalOrgan TransplantationTransplant Recipients

MeSH Terms

COVID-19SARS-CoV-2Antibodies, MonoclonalHumansOrgan TransplantationTransplant Recipients

Keywords

MedicineCoronavirus disease 2019 (COVID-19)Internal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)SerologyCohortPost-hoc analysisAntibodyImmunologyCovid-19Sars-cov-2Monoclonal Antibody TreatmentsPre-exposure Therapy

Sustainable Development Goals

SDG 0: Good health and well-being